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Notre-Dame, Montre´al, Que´bec, CanadaALTHOUGH the etiology of osteoarthritis (OA)
remains elusive, it is currently believed that the
integrity of articular tissue is maintained
through a balance in cytokine-driven anabolic and
catabolic processes.
OA is characterized by a degeneration of articu-
lar cartilage. Breakdown of the cartilage matrix
leads to the development of fibrillation, fissures,
the appearance of gross ulcerations, and full thick-
ness loss of the joint surface. Moreover, at the
clinical stage of the disease, changes caused by
OA involve not only the cartilage, but also the
synovial membrane where an inflammatory
reaction is often seen. The occurrence of synovial
inflammation in OA appears to be of fundamental
importance mainly due to the secretion of
mediators such as the cytokines [1].
Although the spectrum of factors responsible for
the altered function of the cells in OA has not been
fully defined, evidence suggests that the produc-
tion of irregular cytokines and alterations in their
amounts or operative mechanisms contribute to
the abnormalities present.
Among the proinflammatory cytokines, inter-
leukin (IL)-1â and tumor necrosis factor (TNF)-Æ
appear most involved in the catabolic process of
OA [1]. The net e#ect of these proinflammatory
cytokines depends not only on absolute levels, but
on a complex interplay among ambient cytokines.
Other inflammatory cytokines have been shown to
be expressed in synovial membrane or fluid of OA
patients (Fig. 1), these being the IL-6, leukemia
inhibitory factor (LIF), IL-17 and IL-8. All are
upregulated by the proinflammatory cytokines
IL-1â and TNF-Æ, and also have the ability to
increase the synthesis of the two latter.
IL-1â is primarily synthesized as a 31 kD precur-
sor (pro-IL-1â) and must be proteolitically pro-
cessed to be active. In mammals only one protease,
which belongs to the cysteine-dependent protease
family and is named IL-1â converting enzyme
(ICE or Caspase-1), can specifically generate the315mature cytokine. TNF-Æ also occurs in a precursor
membrane-bound form, and is released from cells
by proteolytic cleavage resulting in a soluble
active form. This appears to occur via a TNF-Æ
converting enzyme (TACE) belonging to a
subfamily of the adamalysin (ADAM).
IL-6 has also been proposed as a contributor to
the OA pathological process by increasing the
amount of inflammatory cells in synovial tissue,
inducing a proliferation of chondrocytes, and by
amplifying the e#ects of IL-1 on the increased
metalloprotease (MMP) synthesis and inhibition of
proteoglycan production. However, as IL-6 can
induce the production of TIMP and not MMP
themselves, it is believed that this cytokine is
involved in the feedback mechanism that limits
enzyme damage. LIF is another cytokine that can
stimulate cartilage proteoglycan resorption as
well as MMP synthesis. In OA, however, its role
has not yet been clearly defined. IL-17 is a newly
discovered cytokine that upregulates a number of
gene products involved in cell activation, includ-
ing the pro-inflammatory factors; the role of LIF in
OA remains undetermined. IL-8 is a potent chemo-
tactic cytokine synthesized and secreted mainly by
neutrophils, although it has been detected in other
cell types including OA synovium macrophages,
cells from the lining layer and in chondrocytes.
This cytokine enhances the production of oxidat-
ive and 5-lipoxygenase products and could
synergize with TNF-Æ to markedly increase PGE2
production.
It is now clear that an activation of cytokine
cascades is involved in OA, however apart from
IL-1â and TNF-Æ, the exact role of other inflamma-
tory cytokines has not been clearly established. As
well, it has not yet been determined if they act
independently or in concert, or whether a func-
tional hierarchy exists between them. Yet it is
claimed, and substantiated by studies on animal
models, that IL-1â is of pivotal importance in
cartilage destruction, and TNF-Æ drives the
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cytokines are prime targets for therapeutic
approach.
The understanding of the release and activity of
these cytokines has evolved greatly in recent
years, and a clearer comprehension of their modu-
lating factors as well as their major regulators has
helped to more accurately identify e#ective targets
that may be potentially therapeutic in the treat-
ment of OA. This may occur via a direct or indirect
decrease in the release and/or action of these
factors, and various cytokine-related therapies are
now being considered.
Novel approaches include the inhibition of IL-1â
and TNF-Æ production. Chemical and biologicalagents are currently being evaluated including:
inhibition of the enzyme responsible for the
conversion of IL-1â to an active molecule (ICE),
soluble cytokine receptors, (IL-1 receptor antagon-
ist), antiinflammatory cytokines (IL-4, IL-10 and
IL-13); and targeting of the intracellular signaling
cascades or transcription factors of IL-1â or
TNF-Æ.Proteases
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FIG. 1. Process involved in osteoarthritis. At a later stage of the disease, inflammation of the synovial membrane occurs
from which proteases and proinflammatory cytokines are released, and di#use through the synovial fluid into the
cartilage. This induces additional breakdown of cartilage matrix macromolecules. At this stage, the chondroyctes are
hyperresponsive to cytokine stimulation because of an increased level of cytokine receptors on the cell membrane.
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